Updated Follow-Up of the Phase 1waveLINE-001 Study of Zilovertamab Vedotin in Relapsed or Refractory (R/R) NonHodgkin Lymphoma (NHL)-MedSci.cn

Updated Follow-Up of the Phase 1waveLINE-001 Study of Zilovertamab Vedotin in Relapsed or Refractory (R/R) NonHodgkin Lymphoma (NHL)

Michael, LW; Mei, M; Paul, MB; Jacqueline, CB; de Vos, S; Richard, RF; Patel, K; William, GW; Michael, YC; Kallam, A; Wang, SR; Uzor, CO; Marinello, P; Stephen, ES

AMERICAN JOURNAL OF HEMATOLOGY, 2023; 98 (): S52

科室
- - 订阅+
  - 更多科室
工具
服务